Last Friday saw the USA’s Center for Medicare and Medicaid Services (CMS) announce the selection of 15 new drugs covered ...

UK pharma major AstraZeneca on Friday revealed that Datroway (datopotamab deruxtecan or Dato-DXd) has been approved in the ...

The US Department of Health and Human Services (HHS), through the Centers for Medicare and Medicaid Services (CMS), has ...

The US Food and Drug Administration approved sotorasib (trade name Lumakras) with panitumumab Vectibix), from US biotech ...

Telix Pharmaceuticals (TLX: ASX) has announced a definitive agreement to acquire key assets from ImaginAb, a specialist in ...

Danish diabetes and obesity giant Novo Nordisk today announced headline results from STEP UP, a Phase IIIb trial in the ...

Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of medicines containing semaglutide following ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

German family-owned pharma major Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical ...

T-cell immunotherapy company Atara Biotherapeutics (Nasdaq: ATRA) closed 41% lower on Friday.

The WHO releases draft guidelines on implementing continuous manufacturing in pharmaceuticals, highlighting benefits like ...

Orna Therapeutics and Shanghai Simnova expand their collaboration to develop RNA-based therapies targeting BCMA for multiple ...